Welcome to the EAASM website  

Contact us at enquiries@eaasm.eu to share your experiences of buying medicines online, or receiving medicines from your pharmacist which have seemed out of the ordinary.

The European Alliance for Access to Safe Medicines (EAASM) is an independent, pan-European initiative dedicated to protecting patient safety by ensuring access to safe and legitimate medicines. The Alliance was formed by a cross-section of European stake-holders from a variety of backgrounds. Its key activities include campaigning for the safer use of unlicensed or off-label medicines and also the exclusion of counterfeit and substandard medicines from the supply chain, raising public awareness around such issues, and promoting effective legislation and enforcement in relation to falsified medicines. For a leaflet summarising the EAASM's activities and achievements click here

On this website you will find a wealth of information about counterfeit and substandard medicines. Our top tips section will help you to reassure yourself that the prescription medicine you are buying is genuine. Our news section will provide you with the latest news on counterfeit medicines in Europe and around the world as well as updates about the EAASM activities. The EAASM constantly updates and adds useful resources to the website so you can get as much information as possible about obtaining safe medicines.

Latest News

EAASM addresses The British Medical Journal and Royal College of Physicians Annual Global Conference

7 Dec 2018

Mike Isles, Executive Director of ASOP EU and the EAASM, addressed doctors at the Global Health Horizons – “Learning from the past, looking in to the future” symposium held at the Royal College of Physicians, in London.

Call for Action PROTECTING EUROPEAN CITIZENS BY USING THE MOST SUITABLE SKIN DISINFECTANTS BEFORE MEDICAL TREATMENT

19 Sep 2018

Surgical Site Infections (SSIs), Catheter-Related Infections (CRBSIs) and Blood Culture Contamination (BCC) have become an increasing challenge for European hospitals and healthcare systems for which they pose a significant human and financial burden.